Sponsors

Chromogranin A enzyme-linked immunosorbent assay

Cisbio Bioassays has launched Chromoa, its chromogranin A enzyme-linked immunosorbent assay (ELISA) diagnostic tool. The new kit complements Cisbio’s existing chromogranin A radioimmunoassay (RIACT) kit and can be used by all laboratories for the detection and monitoring of neuroendocrine tumours.

Chromoa is a highly sensitive monoclonal antibody-based assay used to identify increased protein levels in serum when a neuroendocrine tumour is present. The most common neuroendocrine tumours affect the adrenal gland, the pancreas and the digestive track.

Chromogranin A is an increasingly essential analyte for the detection and monitoring of such tumours as well as prostate cancer, which can evolve into an aggressive neuroendocrine form.

Chromoa offers the same reliable results but in an ELISA format. This new kit features a longer shelf life and offers easier stock management, making it a convenient time- and cost-saving alternative. Particularly suitable for laboratories that do not use radioactive kits, ELISA methods have been used for quantitative analysis for several decades and can be adopted by any laboratory.

www.iba-worldwide.com

Latest Issues

Association for Molecular Pathology (AMP) 2024 Annual Meeting & Expo

Hyatt Regency, Vancouver, Canada
19-23 November, 2024

11th Digital Pathology & AI Congress: Europe

Hilton London Metropole, 255 Edgware Road, London, W2 1JU
11-12 December, 2024

Microbiology Society Annual Conference 2025

Liverpool Arena and Convention Centre
31 March - 3 April, 2025

BSMT Annual Microbiology Conference

RAF Museum, Hendon, London NW9 5LL
15 May, 2025

Ghent Pathology 2025

ICC Ghent, Belgium
24-26 June, 2025